SAN

99.11

-3.51%↓

265.5

-0.82%↓

SHL.DE

49.33

-1.62%↓

ARGX

524.6

-3.81%↓

FRE

38.83

-1.89%↓

SAN

99.11

-3.51%↓

265.5

-0.82%↓

SHL.DE

49.33

-1.62%↓

ARGX

524.6

-3.81%↓

FRE

38.83

-1.89%↓

SAN

99.11

-3.51%↓

265.5

-0.82%↓

SHL.DE

49.33

-1.62%↓

ARGX

524.6

-3.81%↓

FRE

38.83

-1.89%↓

SAN

99.11

-3.51%↓

265.5

-0.82%↓

SHL.DE

49.33

-1.62%↓

ARGX

524.6

-3.81%↓

FRE

38.83

-1.89%↓

SAN

99.11

-3.51%↓

265.5

-0.82%↓

SHL.DE

49.33

-1.62%↓

ARGX

524.6

-3.81%↓

FRE

38.83

-1.89%↓

Kodu・Aktsiate loetelu・Almirall SA

A
Almirall SA

Avatud

SektorTervishoid

9.65 -2.33

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.5

Max

9.9

Põhinäitajad
By Trading Economics
Sissetulek	-430K -2.1M
Müük	28M 258M
P/E Sektori keskmine	378.75 63.778
Aktsiakasum	0.04
Dividenditootlus	2.19
Kasumimarginaal	-0.814
Töötajad	2,026
EBITDA	3.9M 45M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+32.96% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.19% 2.39%
Järgmine tulemuste avaldamine	12. mai 2025

Turustatistika
By TradingEconomics
Turukapital	-232M 1.8B
Eelmine avamishind	11.98
Eelmine sulgemishind	9.65

Uudiste sentiment

By Acuity

29%

71%

78 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

9.79 / 10.01 Toetus ja vastupanu

Almirall SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. dets 2024, 07:05 UTC

Market Talk

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Almirall SA Prognoos

Hinnasiht

By TipRanks

32.96% tõus

12 kuu keskmine prognoos

Keskmine 13.03 EUR 32.96%

Kõrge 17 EUR

Madal 10.6 EUR

Põhineb 4 Wall Streeti analüütiku instrumendi Almirall SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Almirall SA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.79 / 10.01Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

78 / 386 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Almirall SA

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.